Leveraging the Client-Provider Interaction to Address Contraceptive Discontinuation: A Scoping Review of the Evidence That Links Them.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
31 12 2021
Historique:
received: 22 03 2021
accepted: 06 09 2021
entrez: 22 12 2021
pubmed: 23 12 2021
medline: 29 3 2022
Statut: epublish

Résumé

Despite considerable investment and effort, unmet need for contraception remains an obstacle to improved family planning outcomes. One influencing factor is the frequency of contraceptive discontinuation among users who desire to prevent pregnancy, often due to method-related concerns and side effects. Contraceptive users have the right to be supported during counseling to voluntarily choose methods that align with their individual needs and preferences. Contraceptive counseling, as a key component of quality of care, is particularly important for providers to reduce unmet need among their clients. This scoping review examined the state of the evidence on contraceptive counseling and its impact on discontinuation. The review first examines the association between quality of care and contraceptive discontinuation, then looks to what the current body of evidence suggests are women's contraceptive counseling priorities, and lastly, explores whether specific counseling tools and approaches have been evaluated with discontinuation as an outcome. The results identified general principles and priorities for good counseling including person-centeredness, client-tailored information exchange, clear and concise information on side effects and bleeding changes, reducing providers' implicit and explicit biases, and trust and respect between the client and provider. The review of the literature also found that evidence to support the use of specific counseling tools and approaches to reduce contraceptive discontinuation is insufficient; research should be designed to determine which specific elements of the client-provider interaction can be improved to significantly impact contraceptive discontinuation. This evidence could inform how the global community of practice might improve and leverage specific counseling approaches and tools to address the most common predictors of discontinuation.

Identifiants

pubmed: 34933989
pii: GHSP-D-21-00235
doi: 10.9745/GHSP-D-21-00235
pmc: PMC8691884
doi:

Substances chimiques

Contraceptive Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

948-963

Informations de copyright

© Danna et al.

Références

Stud Fam Plann. 1990 Mar-Apr;21(2):61-91
pubmed: 2191476
Contraception. 2014 Sep;90(3):280-7
pubmed: 24863169
BMC Fam Pract. 2017 Mar 15;18(1):35
pubmed: 28298197
Stud Fam Plann. 1997 Dec;28(4):278-89
pubmed: 9431649
Contraception. 2017 Oct;96(4):221-226
pubmed: 28756187
Reprod Health. 2018 Jul 16;15(1):128
pubmed: 30012157
Rev Panam Salud Publica. 2008 Jun;23(6):410-7
pubmed: 18644209
Contraception. 2007 Nov;76(5):377-82
pubmed: 17963863
Womens Health Issues. 2015 May-Jun;25(3):209-15
pubmed: 25965154
Afr J Reprod Health. 2003 Aug;7(2):57-73
pubmed: 14677301
Stud Fam Plann. 2002 Jun;33(2):127-40
pubmed: 12132634
Glob Health Sci Pract. 2020 Mar 31;8(1):10-17
pubmed: 32234840
Contraception. 2011 Jan;83(1):5-9
pubmed: 21134497
Contraception. 2017 Sep;96(3):133-137
pubmed: 28645786
Perm J. 2014 Spring;18(2):28-32
pubmed: 24867547
Am J Obstet Gynecol. 2020 Apr;222(4S):S873-S877
pubmed: 31794724
Sex Reprod Healthc. 2018 Jun;16:33-38
pubmed: 29804772
Stud Fam Plann. 2019 Jun;50(2):179-193
pubmed: 31120148
Contraception. 1996 Jun;53(6):357-61
pubmed: 8773423
Soc Sci Med. 2002 May;54(9):1357-68
pubmed: 12058852
Int Fam Plan Perspect. 2003 Jun;29(2):76-83
pubmed: 12783771
Patient Educ Couns. 2010 Dec;81(3):355-61
pubmed: 21093194
Open Access J Contracept. 2016 Mar 31;7:43-52
pubmed: 29386936
J Biosoc Sci. 2012 Jan;44(1):27-41
pubmed: 21933467
Int Fam Plan Perspect. 2005 Mar;31(1):15-23
pubmed: 15888405
Am J Prev Med. 2018 Nov;55(5):725-735
pubmed: 30342635
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41
pubmed: 24135045
Contraception. 2001 Mar;63(3):143-6
pubmed: 11368986
J Health Soc Behav. 2017 Dec;58(4):442-454
pubmed: 29172767
BMC Womens Health. 2014 Feb 13;14(1):28
pubmed: 24524562
Glob Health Sci Pract. 2019 Mar 29;7(1):87-102
pubmed: 30846566
Contraception. 2018 Jan;97(1):34-40
pubmed: 28935217
Int J Gynaecol Obstet. 2017 May;137(2):174-179
pubmed: 28170078
J Pediatr Adolesc Gynecol. 2017 Jun;30(3):395-399
pubmed: 28069493
J Womens Health (Larchmt). 2016 Aug;25(8):832-9
pubmed: 26974353
Glob Health Sci Pract. 2015 Aug 12;3(3):352-7
pubmed: 26374797
Int Perspect Sex Reprod Health. 2009 Jun;35(2):63-71
pubmed: 19620090
Patient Educ Couns. 2016 Oct;99(10):1663-9
pubmed: 27211225
Glob Health Sci Pract. 2018 Oct 4;6(3):603-610
pubmed: 30287535
Patient Educ Couns. 2003 Jun;50(2):113-22
pubmed: 12781926
Am J Obstet Gynecol. 2019 Jun;220(6):565.e1-565.e12
pubmed: 30763545
Contraception. 2018 Nov;98(5):430-437
pubmed: 29733817
Patient Educ Couns. 2017 Feb;100(2):343-348
pubmed: 27578270
Am J Obstet Gynecol. 2016 Jul;215(1):78.e1-9
pubmed: 26827879
Int Fam Plan Perspect. 2005 Dec;31(4):162-71
pubmed: 16439343
Contraception. 2015 Oct;92(4):323-9
pubmed: 26093191
Eur J Contracept Reprod Health Care. 2017 Dec;22(6):418-423
pubmed: 29322814
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Hum Reprod. 2014 Jul;29(7):1393-9
pubmed: 24812309
Health Policy Plan. 2018 Sep 1;33(7):828-839
pubmed: 30010860
Patient Educ Couns. 2010 Dec;81(3):381-7
pubmed: 21074962
Am J Obstet Gynecol. 2017 Feb;216(2):129-134
pubmed: 27776920
Ups J Med Sci. 2016 Nov;121(4):299-303
pubmed: 27646817
Stud Fam Plann. 2018 Jun;49(2):171-179
pubmed: 29708277
Clin Obstet Gynecol. 2014 Dec;57(4):659-73
pubmed: 25264697
Contraception. 2013 Aug;88(2):243-9
pubmed: 22959396
Contraception. 2018 Sep;98(3):210-214
pubmed: 29752923
Int Fam Plann Persp. 1998 Mar;24(1):4-11, 42
pubmed: 11660682

Auteurs

Kendal Danna (K)

Population Services International, Washington, DC, USA. kdanna@psi.org.

Alexandra Angel (A)

Population Services International, Washington, DC, USA.

Jamee Kuznicki (J)

Population Services International, Washington, DC, USA.

Laetitia Lemoine (L)

Population Services International, Washington, DC, USA.

Klaira Lerma (K)

Stanford University, Stanford, CA, USA.
University of Texas at Austin, Austin, TX, USA.

Amanda Kalamar (A)

Population Services International, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH